Biogen Inc. Chief Executive Michel Vounatsos will resign from the company as it slims down its workforce and cuts spending by $1 billion annually.
Biogen’s Aduhelm is the first approved treatment for early stage Alzheimer’s patients that may be able to slow the disease. WSJ explains how the drug interacts with brain cells, and why some doctors aren’t ready to prescribe it yet. Illustration: Jacob ReynoldsBiogen Inc.
Chief Executive Michel Vounatsos will resign from the company as it slims down its workforce, cuts spending by $1 billion annually and attempts to chart a new course after Medicare’s devastating refusal to coverBiogen said Tuesday that Mr. Vounatsos would continue to lead the company and remain on its board until a search for a new CEO is completed.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Change at the top for Biogen after Alzheimer's drug flopsBiogen is looking for a new CEO less than a year after its launch of its Alzheimer’s drug Aduhelm largely fizzled. The company said Tuesday that current CEO Michel Vounatsos will continue to lead the company until his successor is appointed.
Les mer »
Steps star Claire Richards admits she 'struggles everyday' to keep slim figureSteps star Claire Richards has revealed she still struggles with her body image and admits she previously went from 'dangerously thin' to 'obese'
Les mer »
Using WordPress Quizzes for Amazon Alexa Trivia Skills | HackerNoonA quick step-by-step guide on making voice trivia quizzes through a GUI in WordPress.
Les mer »
Pink Opens Up About Personal Mental Health Struggles In Newly Launched Dare To Share Campaign'There are beautiful moments waiting for you, & there are beautiful people waiting to love you, and one of those people is yourself.' Pink shares her experience with mental health struggles in childmindinst's new Dare to Share campaign ⬇
Les mer »
Arizona’s ‘Right to Try 2.0’In 2018, former President Donald Trump signed into law a bill that gave terminally ill patients the right to try experimental drugs not yet approved by the U.S. Food and Drug Administration.
Les mer »
Combat death puts spotlight on Americans fighting in UkraineA former U.S. Marine who died last week in Ukraine was believed to be the first American citizen killed while fighting there.
Les mer »